Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion type Assertion NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_head.
- NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion description "[In contrast, after 5 years, the rate of metachronous contralateral breast cancer in BRCA2 patients was 12% (v 2% in controls; P =.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_provenance.
- NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion evidence source_evidence_literature NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_provenance.
- NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion SIO_000772 10550133 NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_provenance.
- NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion wasDerivedFrom befree-20140225 NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_provenance.
- NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_assertion wasGeneratedBy ECO_0000203 NP440995.RAfW4EfO5bu98Hf7wcvdmbEZbJRHgMYJwxawdQ8mKYL00130_provenance.